A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q).
| Image |  |
|---|---|
| Description | scientific article published on 26 February 2013 |
| Author/s |
author: Michaela Fontenay Pierre Fenaux Olivier Kosmider Valeria Santini Sophie Park |
| Publication date | February 26, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |